AI assistant
Sending…
Protara Therapeutics, Inc. — Director's Dealing 2014
Oct 29, 2014
34057_dirs_2014-10-29_e290f8a0-bf32-44d7-a2b6-73d07183c0a2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PROTEON THERAPEUTICS INC (PRTO)
CIK: 0001359931
Period of Report: 2014-10-27
Reporting Person: Prism Venture Partners V L P (10% Owner)
Reporting Person: Prism Venture Partners V-A LP (10% Owner)
More from Protara Therapeutics, Inc.
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Mar 30
Regulatory Filings
2026
Feb 24
Regulatory Filings
2026
Feb 2
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 27